RxDoctor Payments DataLook up a doctor →

Kristie Callahan

Family · Jackson, MSNPI 1093129231

Payments from drug & device makers

$11,797in general payments, 2019–2025

Across 681 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$936
  • Novartis$827
  • Acadia Pharmaceuticals Inc$727
  • SK Life Science, Inc.$723
  • Pfizer$660
  • UCB, Inc.$561
  • plus $7K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie64$936
Novartis58$827
Acadia Pharmaceuticals Inc46$727
SK Life Science, Inc.35$723
Pfizer42$660
UCB, Inc.31$561
Teva Pharmaceuticals USA, Inc.27$477
Sanofi21$402
Amgen(2 entities)23$393
Argenx US, Inc.18$392
Genentech USA, Inc.27$389
AstraZeneca(2 entities)21$388
Biogen20$379
Lilly USA, LLC24$350
Amylyx Pharmaceuticals, Inc.17$347
Otsuka America Pharmaceutical, Inc.13$308
ANI Pharmaceuticals, Inc.18$307
Catalyst Pharmaceuticals, Inc.9$235
Jazz Pharmaceuticals Inc.11$230
Medtronic15$215
Bristol Myers Squibb14$210
Lundbeck LLC10$202
Biohaven Pharmaceutical Holding Company Ltd.13$198
Avanir Pharmaceuticals, Inc.11$176
Mallinckrodt Hospital Products Inc.5$169
Neurocrine Biosciences, Inc.9$147
Boston Scientific2$142
Impel Pharmaceuticals Inc.6$126
Biohaven Pharmaceuticals, Inc.8$124
Sunovion Pharmaceuticals Inc.6$98
E.r. Squibb & Sons, L.L.C.7$97
Eisai Inc.5$88
Kyowa Kirin, Inc.4$80
Acorda Therapeutics, Inc3$63
Takeda Pharmaceuticals U.S.A., Inc.3$53
Corium, LLC3$50
Alnylam Pharmaceuticals Inc.3$48
Merz Pharmaceuticals, LLC2$47
EMD Serono, Inc.3$44
Tanabe Pharma America, Inc.3$39
Axsome Therapeutics, Inc.2$37
Amneal Pharmaceuticals LLC2$32
Johnson & Johnson2$27
Novocure Inc.1$25
Sumitomo Pharma America, Inc.2$24
MDD US Operations, LLC1$22
TG Therapeutics, Inc.1$22
Grifols USA, LLC1$22
Merck1$20
Vanda Pharmaceuticals Inc.1$18
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$16
Mylan Specialty L.p.1$16
Cala Health, Inc.1$16
Idorsia Pharmaceuticals US Inc1$15
Kedrion Biopharma, Inc.1$14
Livanova USA, Inc.1$12
Supernus Pharmaceuticals, Inc.1$12

How this compares

$11,797 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi →

Medicare billing

Part B allowed, 2024
$110,357
Medicare patients
827
Services billed
2,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Jackson

See the full list for Mississippi →

Where these figures come from

Is this you, or does something look wrong? →